Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,733 shares of Class A Common Stock for an average price of $12.4442 under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.59 million as part of a pre-arranged trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.5 million under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.46 million under a pre-arranged 10b5-1 trading plan on September 19, 2025.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 122,733 shares of Class A Common Stock for approximately $1.46 million under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.44 million under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $12.01 per share under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines converted over 3 million Class B shares to Class A and transferred 5 million Class B shares to a trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines sold 9,988 shares of Class A Common Stock at $12 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 Class A Common Stock shares on July 30, 2025, under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 Class A Common Stock shares on July 29, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a planned sale of 45,000 Class A Common Stock shares on July 28, 2025, under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for an average price of $12.2478 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a pre-planned sale of 45,000 Class A Common Stock shares on July 24, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $565,402.50, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $12.72 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines disclosed a pre-planned sale of 45,000 shares of Class A Common Stock at an average price of $12.3812, effective July 18, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath, Inc. CEO and Chairman Daniel Dines has filed a Form 4 indicating a planned sale of 45,000 shares of Class A Common Stock on July 17, 2025, under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 disclosing a pre-arranged sale of 45,000 Class A Common Stock shares scheduled for July 16, 2025, under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 shares of Class A Common Stock on July 15, 2025, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines filed a Form 4 disclosing the sale of 45,000 shares of Class A Common Stock on July 14, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines filed a Form 4 disclosing a planned sale of 45,000 shares of Class A Common Stock on July 11, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported a planned sale of 45,000 shares of Class A Common Stock on July 10, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported a planned sale of 45,000 shares of Class A Common Stock through a Rule 10b5-1 trading plan, effective July 9, 2025.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 Class A Common Stock shares on July 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $13.1137 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 shares of Class A Common Stock on July 3, 2025, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 Class A Common Stock shares on July 2, 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Operating and Financial Officer, Ashim Gupta, sold 56,322 shares of Class A Common Stock for approximately $716,900 through a pre-arranged Rule 10b5-1 trading plan.